FDA revision allows pharmacists to prescribe COVID-19 treatment Paxlovid
The Food and Drug Administration on Monday revised its emergency use authorization of Paxlovid, allowing pharmacists to prescribe the anti-viral drug used to treat COVID-19.
The Food and Drug Administration on Monday revised its emergency use authorization of Paxlovid, allowing pharmacists to prescribe the anti-viral drug used to treat COVID-19.